Searchable abstracts of presentations at key conferences in endocrinology

ea0045p20 | Diabetes | BSPED2016

Acute mononeuropathy as a first presentation of Type 1 Diabetes Mellitus

Kapoor Sonal , Sundaram Prem , Tziaferi Vaya , Prasad Manish

Introduction: Diabetic neuropathy is often a late manifestation of diabetes. Moreover its incidence in the paediatric age group is very rare. We present here a case of motor neuropathy as a first presenting feature of Type 1 diabetes mellitus.Case Report: A fourteen-year-old girl presented with right foot drop, which had progressively worsened over the last ten days. There was no other CNS or systemic involvement. Parents denied any history of pain, para...

ea0074ncc64 | Highlighted Cases | SFENCC2021

A case of sight threatening pituitary macro-adenoma in pregnancy

Krishna Prasad Savi Prabha , Vachhani Shyamsunder , Das Gautam

Introduction: Pituitary adenomas account for 10% of intracranial tumours and are almost always benign. In some individuals, who may have a pre-existing adenoma, the pituitary gland undergoes remarkable hyperplasia especially during pregnancy, due to increase in oestrogen levels leading to increase in the tumour volume causing mass effects. This case report reviews a pregnancy with incidental finding of pituitary macro adenoma causing visual field defect, its management and fur...

ea0075p03 | Pituitary and neuroendocrinology | EYES2021

A rare case report of FSH secreting pituitary adenoma with apoplexy

Ravindra Shruthi , Shetty Sahana , Prasad Lakshmi , Nayak Raghavendra

Background: FSH (Follicular stimulating hormone) secreting pituitary adenoma rare entity among functional pituitary tumors, with a few reported cases, almost certainly missed because of the lack of clinical examination skills. Approximately, 40-50% represent gonadotroph adenoma of all pituitary tumors. Only small percentage of these tumors secrete biologically active gonadotropins leading to gonadal stimulation.Case presentation: Here, we report a unique...

ea0077p11 | Adrenal and Cardiovascular | SFEBES2021

SGPL1 regulates expression of electron transport chain components to modulate cellular metabolism in the adrenal gland

Williams Jack , Smith Chris , Maharaj Avinaash , Kwong Ruth , Hall Charlotte , Metherell Lou , Prasad Rathi

Introduction: Sphingosine-1-phosphate lyase (SGPL1) catalyses the final step in sphingolipid metabolism, irreversibly degrading the lipid signalling molecule sphingosine-1-phosphate (S1P). The relative abundance of S1P compared to its precursors sphingosine and ceramide finely tunes signal transduction for a wide range of cellular pathways including proliferation, apoptosis, migration and calcium handling. Loss-of-function mutations in SGPL1 cause a spectrum of disorders, incl...

ea0051oc5.3 | Oral Communications 5 | BSPED2017

Novel evidence implies that ALADIN, the triple A syndrome gene product is involved in mitochondrial physiology

Da Costa Alexandra Rodrigues , Meimaridou Eirini , Prasad Rathi , Metherell Louise A. , Chapple J. Paul , Storr Helen L.

Triple A syndrome (AAAS), a rare and debilitating autosomal recessive disorder. It is characterised by adrenal failure, alacrima and achalasia; ~70% patients develop a neurodegeneration. The AAAS gene encodes ALADIN, a nuclear pore complex (NPC) protein necessary for the selective nuclear import of DNA protective molecules and is important for cellular redox homeostasis. ALADIN’s role is not fully characterised: its discovery at the centrosome and the endoplasmic...

ea0081p356 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Prevalence and awareness of complications in type 2 diabetes mellitus : a hospital based comparative cross-sectional study

Mainali Uttar Kumar , Kamat Laxmi Narayan , Khatri Sanjeep , Acharya Den Prasad

Introduction: Diabetes Mellitus appears to be globally pandemic and is drawing attention as a major public health concern. Chronic complications of this disease can lead to poor quality of life with significant financial burden to family and country as well. The current study aims to assess prevalence of such complications and its awareness in type 2 diabetes population.Methods: This descriptive cross-sectional study was conducted during one year period ...

ea0081ep735 | Pituitary and Neuroendocrinology | ECE2022

Endocrine treatment of anabolic-androgenic steroid induced hypogonadism in males: A pilot study

Christian Bordado Henriksen Hans , Palmstrom Jorgensen Anders , Bjornebekk Astrid , Neupane Sudan Prasad , A. Havnes Ingrid

Background and aims: Non-prescribed use of anabolic-androgenic steroids (AAS) is associated with a wide range of health risks including AAS-induced hypogonadism (ASIH) caused by negative feedback suppression on the hypothalamic-pituitary-gonadal (HPG) axis. Testicular function might be reduced for months up to years after AAS-cessation, increasing the risk of developing fatigue, decreased libido, erectile dysfunction, infertility, sleep disorder, depression and anxiety. There ...

ea0085oc5.3 | Oral Communications 5 | BSPED2022

UK protocol for induction of puberty with gonadotropins in males with hypogonadotropic hypogonadism

Dunkel Leo , Prasad Rathi , Martin Lee , Senniappan Senthil , Butler Gary , Howard Sasha

Hypogonadotropic hypogonadism (HH) is a rare reproductive disorder that results in a lack of normal pubertal development and reduced potential for fertility in adult life. The condition is characterised by low circulating sex steroid concentrations resulting from a deficiency of pituitary gonadotropin production. HH may be congenital or acquired, most commonly due to tumour or treatment for malignant disease. When associated with anosmia it is termed Kallmann syndrome. HH is a...

ea0085oc5.8 | Oral Communications 5 | BSPED2022

SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiency

Ming Wai Kwong Ruth , Williams Jack , Maharaj Avinaash V , Metherell Lou , Prasad Rathi

Sphingosine-1-phosphate lyase 1 insufficiency syndrome (SPLIS) is a multisystemic syndrome in which primary adrenal insufficiency (PAI) and steroid resistant nephrotic syndrome predominate, secondary to loss-of-function mutations in SGPL1 (sphingosine-1-phosphate lyase). SGPL1 carries out the irreversible breakdown of sphingosine-1-phosphate, a bioactive sphingolipid intermediate, with implicated roles in various cellular processes. Wider endocrinopathy including gonadal insuf...

ea0065p48 | Adrenal and Cardiovascular | SFEBES2019

Twenty-five years of familial glucocorticoid deficiency: genotypic and phenotypic variability

Smith CJ , Maharaj AV , Prasad R , Hughes C , Qamar Y , Clark AJL , Chan LF , Metherell LA

Within the last 25 years more than 400 cases with suspected Familial Glucocorticoid Deficiency (FGD) have been referred to our centre for genetic testing. All cases had low or undetectable serum cortisol paired with an elevated plasma ACTH level. Our patient cohort comprises 352 families from 30 different nationalities and ranges from neonates to patients in their eighties. In 1993 the first gene defect, in MC2R, was discovered by candidate gene sequencing. Subsequent...